| Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney Y Yuan, M Sun, Z Jin, C Zheng, H Ye, H Weng European journal of pharmacology 943, 175560, 2023 | 9 | 2023 |
| Effects of sodium-glucose co-transporter 2 inhibitors on liver fibrosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: An updated meta-analysis of … Z Jin, Y Yuan, C Zheng, S Liu, H Weng Journal of Diabetes and its Complications 37 (8), 108558, 2023 | 8 | 2023 |
| Astragalin ameliorates renal injury in diabetic mice by modulating mitochondrial quality control via AMPK-dependent PGC1α pathway M Sun, H Ye, C Zheng, Z Jin, Y Yuan, H Weng Acta pharmacologica Sinica 44 (8), 1676-1686, 2023 | 5 | 2023 |
| FTY‐720 alleviates diabetes‐induced liver injury by inhibiting oxidative stress and inflammation H Ye, M Sun, Z Jin, Y Yuan, H Weng Fundamental & Clinical Pharmacology 37 (5), 960-970, 2023 | 1 | 2023 |
| Dapagliflozin ameliorates hepatic steatosis via suppressing LXRα-mediated synthesis of lipids and bile acids Z Jin, R Yin, Y Yuan, C Zheng, P Zhang, Y Wang, H Weng Biochemical Pharmacology 223, 116167, 2024 | | 2024 |
